PharmMD, the nation's leader in quality Medication Therapy Management (MTM), today announced Janet Petraroi as Chief Financial Officer and Michael Ansel as Chief Development Officer.
"The new appointments for Ms. Petraroi and Mr. Ansel will advance our objective to being the nation's leader in MTM and support our business growth strategy," says Bo Bartholomew, CEO of PharmMD.
Janet Petraroi, CPA joins PharmMD as Chief Financial Officer. She previously served as Principal at Professional Accounting and Management Services and Professional Alliance for Managed Care Services. She has over 25 years of financial and accounting experience in the health care industry, holding senior level positions with companies such as FOCUS Healthcare, Coventry Corporation and Equicor Health Plan. Petraroi is a Certified Public Accountant and received her B.S. in Business Administration from Old Dominion University.
Michael Ansel has been named Chief Development Officer at PharmMD. Ansel had previously served as PharmMD's Vice President of Sales. In his new role, he is responsible for driving all business development efforts for PharmMD and managing a national team of sales executives. "Michael has been a major contributor to PharmMD's exponential growth and management team," says Bartholomew. "His appointment as Chief Development Officer is a result of his track record of success at increasing sales for the past few years."
About PharmMD
PharmMD is the quality leader in Medication Therapy Management Solutions. Based in Brentwood, Tenn., PharmMD works with employers and health plans to prevent medication related health problems through the application of the best pharmacist and physician knowledge using their proprietary MTM software. Founded in 2006, PharmMD improves coordination and communication among physicians, pharmacists, payers and patients by analyzing pharmacy and medical claims information and clinical decision making. Because PharmMD focuses exclusively on MTM, the company is able to analyze both aggregate and patient-specific data to identify trends and conflicts to positively impact patient health and contain costs. More information at: www.pharmmd.com.
Contacts:
PharmMD
Holly Flontek, 615-312-7072
Holly.Flontek@pharmmd.com
